CD19 and severe combined immunodeficiency: Our data demonstrate that conditioned TCRαβ/CD19-depleted haploidentical grafts are a safe and effective alternative for infants with SCID who lack HLA-matched family donors and support the use of conditioning pre-HSCT to improve long-term immunological recovery.